Oxford Biomedica (OXB) Share Price, News & Analysis

Company Overview

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, and adenoviral vectors. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.

Key Stats

• Today's Range: 412 to 426.50
• 50-Day Range: 363.50 to 445
• 52-Week Range: 167 to 450
• Volume: 423,996 shs
• Average Volume: 200,833 shs
• Market Capitalization: £449.36 million
• P/E Ratio: N/A
• Dividend Yield: 4.57%
• Price Target: GBX 433.33
• Consensus Rating: Hold

OXB Stock Analysis - Frequently Asked Questions

How have OXB shares performed this year?

Oxford Biomedica's stock was trading at GBX 220 at the start of the year. Since then, OXB shares have increased by 93.9% and is now trading at GBX 426.50.
View the best growth stocks for 2024 here.

How do I buy shares of Oxford Biomedica?

Shares of OXB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Oxford Biomedica own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Oxford Biomedica investors own include EnQuest (ENQ), Petra Diamonds (PDL), Sirius Minerals (SXX), Centamin (CEY), Lloyds Banking Group (LLOY), Oxford Biomedica (OXBDF) and Barclays (BARC).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: LON:OXB
• CUSIP: N/A
• CIK: N/A
• Web: www.oxfordbiomedica.co.uk
• Phone: +44-1865-783000
• Fax: N/A
• Employees: 891
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: GBX 433.33
• High Stock Price Target: GBX 740
• Low Stock Price Target: GBX 180
• Potential Upside/Downside: +1.6%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 3 Analysts

Profitability

• EPS (Most Recent Fiscal Year): GBX (1.44)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-142,020,000.00
• Net Margins: -145.98%
• Pretax Margin: N/A
• Return on Equity: -124.66%
• Return on Assets: -12.67%

Debt

• Debt-to-Equity Ratio: 154.88
• Current Ratio: 2.35
• Quick Ratio: 1.67

Sales & Book Value

• Annual Sales: £97.28 million
• Price / Sales: 4.62
• Cash Flow: GBX 141.86 per share
• Price / Cash Flow: 3.01
• Book Value: GBX 63 per share
• Price / Book: 6.77

Miscellaneous

• Outstanding Shares: 105,360,000
• Free Float: N/A
• Market Cap: £449.36 million
• Optionable: Not Optionable
• Beta: 1.09